Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 3Gastrointestinal 3Plasma cell 2Head & Neck 2Breast 2

Conditions

cyclopia sequence 2Neoplasms, Plasma Cell 2Multiple Myeloma 2

Interventions

Dexamethasone 374Lenalidomide 206Bortezomib 201Cyclophosphamide 178Melphalan 135Calcium Dobesilate 120daratumumab 107pomalidomide 74carfilzomib 74fludarabine phosphate 71Peripheral Blood Stem Cell Transplantation 66Thalidomide 57Filgrastim 57Mycophenolic Acid 56Busulfan 55Tacrolimus 48Granulocyte Colony-Stimulating Factor 47ixazomib 45fludarabine 45Whole-Body Irradiation 44dexamethasone acetate 36Cyclosporine 35isatuximab 34Etoposide 34Antilymphocyte Serum 32dexamethasone 21-phosphate 30elotuzumab 28auricularum 27Prednisone 27plerixafor 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Minocycline × Plasma cell × Clear all
NCT01283997 2024-06-13

Prevention of Treatment Induced Neuropathy in Multiple Myeloma

M.D. Anderson Cancer Center

Phase 2 Completed
79 enrolled 10 charts
Plasma cell

cyclopia sequence, Multiple Myeloma, Neoplasms, Plasma Cell

NCT01793051 2021-11-24

Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma

M.D. Anderson Cancer Center

Phase 2 Completed
88 enrolled 6 charts
Plasma cell

cyclopia sequence, Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡